INFU vs PACB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 14, 2026

INFU

35.8
AI Score
VS
PACB Wins

PACB

52.2
AI Score

Investment Advisor Scores

INFU

36score
Recommendation
SELL

PACB

52score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric INFU PACB Winner
Revenue 70.62M 76.19M PACB
Net Income 4.25M -53.02M INFU
Gross Margin 58.2% 33.4% INFU
Net Margin 6.0% -69.6% INFU
Operating Income 5.74M -52.97M INFU
ROE 7.2% 159.6% PACB
ROA 4.3% -7.1% INFU
Total Assets 97.70M 751.85M PACB
Cash 964,000 61.00M PACB
Current Ratio 2.50 4.92 PACB
Free Cash Flow 7.50M -84.87M INFU

Relative Price Performance (Last 90 Days)

INFU 1M: +37.3% · 3M: +22.8% PACB 1M: -3.6% · 3M: +8.0%

Current Technical Phase

INFU

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (9.7% over 20 days), RSI 65

RSI (14): 64.5 · Price: $12.21

PACB

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 53.8 · Price: $1.35

Fundamentals Snapshot

Metric INFU PACB
Market Cap
Forward P/E 21.8 -3.3
Trailing P/E 30.5
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin 0.6% 0.3%
Operating Margin 0.1% -1.1%
EPS 0.40 -0.41
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, PACB is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.